These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 32338450

  • 1. Temporal volume increase after reduction of masseteric hypertrophy utilizing incobotulinumtoxin type A.
    Nikolis A, Enright KM, Rudolph C, Cotofana S.
    J Cosmet Dermatol; 2020 Jun; 19(6):1294-1300. PubMed ID: 32338450
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of Botulinum Toxin in Treating Asian Indian Patients with Masseter Hypertrophy: A 4-Year Follow-Up Study.
    Shome D, Khare S, Kapoor R.
    Plast Reconstr Surg; 2019 Sep; 144(3):390e-396e. PubMed ID: 31461011
    [Abstract] [Full Text] [Related]

  • 3. The topographic anatomy of the masseteric nerve: A cadaveric study with an emphasis on the effective zone of botulinum toxin A injections in masseter.
    Kaya B, Apaydin N, Loukas M, Tubbs RS.
    J Plast Reconstr Aesthet Surg; 2014 Dec; 67(12):1663-8. PubMed ID: 25175271
    [Abstract] [Full Text] [Related]

  • 4. Anatomical Considerations When Treating Compensatory Hypertrophy of the Upper Part of the Masseter after Long-Term Botulinum Neurotoxin Type A Injections.
    Lee KL, Cho HJ, Bae H, Park HJ, Park MS, Kim HJ.
    Toxins (Basel); 2020 Mar 22; 12(3):. PubMed ID: 32235784
    [Abstract] [Full Text] [Related]

  • 5. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement.
    Kim HJ, Yum KW, Lee SS, Heo MS, Seo K.
    Dermatol Surg; 2003 May 22; 29(5):484-9. PubMed ID: 12752515
    [Abstract] [Full Text] [Related]

  • 6. Bilateral hypertrophy of masseteric and temporalis muscles, our fifteen patients and review of literature.
    Graziano P, Dell'Aversana Orabona G, Astarita F, Ponzo LM, Nunziata R, Salzano G, Maglitto F, Solari D, Santella A, Cappabianca M, Iaconetta G, Califano L.
    Eur Rev Med Pharmacol Sci; 2016 May 22; 20(1):7-11. PubMed ID: 26813447
    [Abstract] [Full Text] [Related]

  • 7. The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy.
    Ahn KY, Kim ST.
    Plast Reconstr Surg; 2007 Nov 22; 120(6):1662-1666. PubMed ID: 18040203
    [Abstract] [Full Text] [Related]

  • 8. Botulinum Toxin Injections for Masseter Reduction in East Asians.
    Cheng J, Hsu SH, McGee JS.
    Dermatol Surg; 2019 Apr 22; 45(4):566-572. PubMed ID: 30883483
    [Abstract] [Full Text] [Related]

  • 9. Effects of botulinum toxin type A on contouring of the lower face.
    Choe SW, Cho WI, Lee CK, Seo SJ.
    Dermatol Surg; 2005 May 22; 31(5):502-7; discussion 507-8. PubMed ID: 15962731
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin type A treatment for contouring of the lower face.
    Park MY, Ahn KY, Jung DS.
    Dermatol Surg; 2003 May 22; 29(5):477-83; discussion 483. PubMed ID: 12752514
    [Abstract] [Full Text] [Related]

  • 11. A Multicenter Phase II Study Evaluating the Safety and Efficacy of Botulax in Asian Patients with Benign Masseteric Hypertrophy.
    Lee JS, Son HS, Kim BJ, Lee YW.
    Plast Reconstr Surg; 2024 May 01; 153(5):910e-918e. PubMed ID: 37335589
    [Abstract] [Full Text] [Related]

  • 12. Ultrasonographic Considerations for Safe and Efficient Botulinum Neurotoxin Injection in Masseteric Hypertrophy.
    Lee HJ, Jung SJ, Kim ST, Kim HJ.
    Toxins (Basel); 2021 Jan 04; 13(1):. PubMed ID: 33406757
    [Abstract] [Full Text] [Related]

  • 13. Literature review of the adverse events associated with botulinum toxin injection for the masseter muscle hypertrophy.
    Yeh YT, Peng JH, Peng HP.
    J Cosmet Dermatol; 2018 Oct 04; 17(5):675-687. PubMed ID: 30091170
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and Safety of a Novel Botulinum Toxin A for Masseter Reduction: A Randomized, Double-Blind, Placebo-Controlled, Optimal Dose-Finding Study.
    Hong JY, Jeong GJ, Kwon TR, Kim JH, Li K, Kim BJ.
    Dermatol Surg; 2021 Jan 01; 47(1):e5-e9. PubMed ID: 33347002
    [Abstract] [Full Text] [Related]

  • 15. Botulinum toxin a for lower facial contouring: a prospective study.
    Yu CC, Chen PK, Chen YR.
    Aesthetic Plast Surg; 2007 Jan 01; 31(5):445-51; discussion 452-3. PubMed ID: 17674088
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Electrophysiologic change and facial contour following botulinum toxin A injection in square faces.
    Lee CJ, Kim SG, Kim YJ, Han JY, Choi SH, Lee SI.
    Plast Reconstr Surg; 2007 Sep 01; 120(3):769-778. PubMed ID: 17700130
    [Abstract] [Full Text] [Related]

  • 18. Botulinum toxin for masseter hypertrophy.
    Fedorowicz Z, van Zuuren EJ, Schoones J.
    Cochrane Database Syst Rev; 2013 Sep 09; 2013(9):CD007510. PubMed ID: 24018587
    [Abstract] [Full Text] [Related]

  • 19. Botulinum toxin for masseter hypertrophy.
    Al-Muharraqi MA, Fedorowicz Z, Al Bareeq J, Al Bareeq R, Nasser M.
    Cochrane Database Syst Rev; 2009 Jan 21; (1):CD007510. PubMed ID: 19160335
    [Abstract] [Full Text] [Related]

  • 20. Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy.
    Arikan OK, Tan FU, Kendi T, Koc C.
    J Otolaryngol; 2006 Feb 21; 35(1):40-3. PubMed ID: 16527016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.